A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure
Stopped After 2 patients it was concluded that a large change in exclusion criteria and study design was needed to obtain the ojective for the study
Conditions
- Heart Failure
- Cardio-Renal Syndrome
Interventions
Sponsor
Triomed AB